The Latest
-
Sorrento Therapeutics CEO on focusing on ‘the real deal’ antibody test rather than stock performance
-
Target sales surge in Q1 earnings, online sales up 141%
-
Lowe’s profit, sales surged in Q1
-
Luckin Coffee shares crash on delisting risk